CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Current Assets:
Cash and cash equivalents	$ 28,404	$ 6,911
Marketable securities	953	1,973
Receivables	5,667	5,965
Inventories	1,308	1,195
Other assets, current	1,384	1,116
Total current assets	37,716	17,160
Property, plant and equipment	4,849	5,027
Goodwill	6,533	6,538
Other intangible assets	995	1,091
Deferred income taxes	1,442	1,371
Marketable securities	994	1,775
Other assets	2,634	2,024
Total Assets	55,163	34,986
Current Liabilities:
Short-term debt obligations	545	1,703
Accounts payable	2,005	1,892
Other liabilities, current	7,161	7,059
Total Current Liabilities	9,711	10,654
Accrued Income Taxes, Noncurrent	2,971	3,043
Other liabilities, noncurrent	1,897	1,516
Long-term debt	24,433	5,646
Total Liabilities	39,012	20,859
Bristol-Myers Squibb Company Shareholders' Equity:
Preferred stock	0	0
Common stock	221	221
Capital in excess of par value of stock	2,150	2,081
Accumulated other comprehensive loss	(2,621)	(2,762)
Retained earnings	35,870	34,065
Less cost of treasury stock	(19,571)	(19,574)
Total Bristol-Myers Squibb Company Shareholders' Equity	16,049	14,031
Stockholders' Equity Attributable to Noncontrolling Interest	102	96
Total Equity	16,151	14,127
Total Liabilities and Equity	$ 55,163	$ 34,986